IL6 and metabolic bone disorder: For example, an earlier study applied an interactome analysis approach (Figure 4A) and identified leptin, tumour necrosis factor, interleukin-6 (IL-6) and parathyroid hormone as candidate biomarkers for CVDs and bone metabolism disorders in CKD patients [116].